Research
Our laboratory is specialized in protein engineering, which we apply to develop novel immunotherapies for cancer, regenerative medicine, and other immune-related diseases. The goal of our research is to innovate effective and safe immunotherapies for clinical use. By doing so, we develop novel immunoengineering tools to address key questions in immunology.
A primary focus in our laboratory is the engineering of immune-signaling molecules (e.g., cytokines) and cell-based therapies (e.g., CAR-T cells) for targeted delivery to inflamed tissues, particularly by modulating their interactions with the extracellular matrix. Another important focus is the engineering of synthetic membrane receptors in living cells and the characterization of their clustering and signaling properties, as a potential new avenue to create next-generation protein and cell-based therapeutics.
Keywords:
Immunoengineering, cancer, regenerative medicine, therapeutic proteins, cell-based therapies.
“At the intersection of immunology and engineering, we push the boundaries in the fight against disease.”